Large Chicago study Abs #0535 at #ACR23 biologic tx prescribed more often for males, Non-Hispanic Blacks and Latinx in AS. Low SES, measured by SDI, and insurance status did not affect if pt received bDMARD. https://t.co/MdDuNPMCC9 @rheumnow https://t.co/Oa9aC3rbb0

Join us tonight at 6pm PT/ 9pm ET for our daily #ACR23 recap. https://t.co/0RDwTdzhwS

ACR convergence highlights by the awesome, i mean very awesome team @RheumNow Sunday to Thursday with recap Friday 🤓 i am stocking every one😂 https://t.co/WahAoH7MCM Biologic / target synthetic induced None melanoma skin cancer? Disease induced or medication induced ?

I never tire of hearing this story. Biologic DMARDs revolutionized rheumatology & changed millions of lives. How did we get TNFi? Sharp translational insights & courage++ After 4w, RA gone, up/down stairs like a miracle. Sir Ravinder 'Tiny' Maini #ACR23 Global Summit @RheumNow https://t.co/Je1cz3cWG5

Big Pharma – Pay attention! When developing new therapeutics, consider delivery, cost, climate sensitivity and sustainability #GlobalSummit @ACRheum @rheumnow #ACR23 https://t.co/ThqnTI3SNm

Opportunities to address healthcare inequities: generics/biosimilars, fair pricing, and inclusive business models. #GlobalSummit @RheumNow #ACR23 @ACRheum https://t.co/ynJWWcCqWo